Long-term Study in Patients Under Anti-retroviral Combination Therapy Switching to Viramune®

A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV

NCT07053384 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Open-Label Multi-Centre Randomised Switch Study to Evaluate Virological Efficacy Over 96Weeks Of 2-Drug Therapy With Dolutegravir(DTG)/Rilpivirine(RPV) Fixed Dose Combination(FDC) in Antiretroviral Treatment-Experienced HIV-1 Infected Subjects Virologically Suppressed With NNRTI Mutation K103N

NCT05349838 ·Status: COMPLETED ·Phase: PHASE3

Second-line Therapy Antiretroviral in Patients Who Failed Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) - Based Regimens

NCT00627055 ·Status: COMPLETED ·Phase: PHASE4

A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions

NCT00144248 ·Status: COMPLETED ·Phase: PHASE4

ALternative TEnofovir Dosing in Adults With Moderate Renal Function Impairment

NCT01671982 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial to Evaluate the Efficacy, Pharmacokinetics (PK) Interactions and Safety of Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in HIV-1-Infected Solid Organ Transplant Patients

NCT03360682 ·Status: COMPLETED ·Phase: PHASE4

CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes

NCT00966160 ·Status: COMPLETED ·Phase: PHASE3

Comparing Immune Activation and Latent HIV Reservoir Size Between People Living With HIV on Tenofovir-containing Versus NRTI-free ART

NCT05584397 ·Status: ENROLLING_BY_INVITATION

A Long-term Follow-up of the HIV-NAT Cohort

NCT00411983 ·Status: RECRUITING

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF

NCT01252940 ·Status: COMPLETED ·Phase: PHASE3

A Trial With TMC278-TIDP6-C222 for Continued TMC278 Access in Patients Infected With Human Immunodeficiency Virus-1

NCT01266902 ·Status: COMPLETED ·Phase: PHASE3

Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults

NCT01968551 ·Status: COMPLETED ·Phase: PHASE3

Observational Study of HIV-Infected Subjects With X4-Tropic or Non-Phenotypeable Virus

NCT00321438 ·Status: TERMINATED

Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl

NCT00532168 ·Status: COMPLETED ·Phase: PHASE4

Switch Study to Evaluate F/TAF in HIV-1 Positive Participants Who Are Virologically Suppressed on Regimens Containing FTC/TDF

NCT02121795 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Replacement of Reverse Transcriptase Nucleoside/Nucleotide Inhibitors by Nevirapine in Patients on Triple Treatment With Analogues Only

NCT00415090 ·Status: COMPLETED ·Phase: PHASE4

Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects

NCT00966329 ·Status: COMPLETED ·Phase: PHASE4

DOR/TDF/3TC Switch With M184V/I in People With Controlled HIV (Drive Off-Road)

NCT06034938 ·Status: RECRUITING ·Phase: PHASE2

Pharmacokinetics of Islatravir in Participants With Severe Renal Impairment (MK-8591-026)

NCT04303156 ·Status: COMPLETED ·Phase: PHASE1

Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection

NCT00062660 ·Status: APPROVED_FOR_MARKETING

Tenofovir DF (Disoproxil Fumarate) in Combination With Emtricitabine in HIV-1 Patients

NCT00106379 ·Status: COMPLETED ·Phase: PHASE4

Safety and Effect on HIV Transcription of Vorinostat in Patients Receiving Suppressive Combination Anti-retroviral Therapy

NCT01365065 ·Status: UNKNOWN ·Phase: PHASE2

Lopinavir/r Monotherapy as Maintenance Therapy After Long Term Viral Suppression

NCT00160849 ·Status: COMPLETED ·Phase: PHASE4

Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects.

NCT00460746 ·Status: COMPLETED ·Phase: PHASE3

Monitored Antiretroviral Pause in Chronic HIV-Infected Subjects With Long-Lasting Suppressed Viremia

NCT03198325 ·Status: COMPLETED ·Phase: NA